http://purl.org/np/RAD28Nl4h_... RAD28Nl4h_

links a nanopublication to its provenance http://www.nanopub.org/nschema#hasProvenance provenance

http://www.w3.org/ns/prov#wasAttributedTo wasAttributedTo

https://orcid.org/0000-0002-3668-2627 Elif Ozkan

Elif Ozkan

2022-10-13T13:58:05.814Z

http://purl.org/np/RAD28Nl4h_... RAD28Nl4h_

links a nanopublication to its provenance http://www.nanopub.org/nschema#hasProvenance provenance

http://www.w3.org/ns/prov#generatedAtTime generatedAtTime

2022-10-13T13:58:05.814670

Elif Ozkan

2022-10-13T13:58:05.814Z

http://purl.org/np/RAD28Nl4h_... RAD28Nl4h_

links a nanopublication to its provenance http://www.nanopub.org/nschema#hasProvenance provenance

http://www.w3.org/ns/prov#wasQuotedFrom wasQuotedFrom

Ribavirin is indicated for the treatment of chronic Hepatitis C virus (HCV) infection in combination with other antiviral agents. The addition of ribavirin in Technivie therapy indicated for treating HCV genotype 1a and 4 infections is recommended in patients with or without cirrhosis. Typically added to improve SVR and reduce relapse rates 6.9% of patients.

Elif Ozkan

2022-10-13T13:58:05.814Z